Company
United StatesPublic company, NASDAQ: ADPTAdaptive Biotechnologies Corp (NASDAQ: ADPT), Bothell, WA – FDA Inspections
Inspection records and compliance data for Adaptive Biotechnologies Corp in Bothell, Washington. 2 FDA inspections on record, last inspected October 24, 2025. Publicly traded as NASDAQ: ADPT.
Company Profile
This profile covers Adaptive Biotechnologies Corp based in Bothell, Washington, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected October 29, 2021. Last inspected October 24, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 24, 2025 | Not classified | Medical Devices & Rad Health | 1290504 |
| October 29, 2021 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1156030 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Adaptive Biotechnologies Corp
Stock ticker
ADPT
Exchange
NASDAQ
Share price
$29.48
Market cap
$4.8B
Price as of
November 13, 2026
FEI Number
3009879426
Address
19910 N Creek Pkwy, Bothell, Washington 98011, United States
Country
United States
ID: 3db3c46d-9d98-47f2-9209-d87e69291021